INVOKANA, also known by its generic name canagliflozin, is a prescription medication used primarily in the management of type 2 diabetes. It belongs to a class of drugs known as sodium-glucose cotransporter 2 (SGLT2) inhibitors, which work by helping the kidneys remove glucose from the bloodstream through the urine, thereby lowering blood sugar levels. INVOKANA is often prescribed in conjunction with diet and exercise to improve glycemic control in adults with type 2 diabetes. It is not used for the treatment of type 1 diabetes or diabetic ketoacidosis. As with any medication, it is important to use INVOKANA under the guidance of a healthcare provider, as it may have side effects and may not be suitable for everyone.
When using INVOKANA, a medication primarily prescribed for the management of type 2 diabetes, it is crucial to adhere strictly to your doctor's instructions and thoroughly read the label that accompanies the medicine. This ensures you are aware of the correct dosage and any potential interactions with other medications you might be taking. It's important to inform your doctor about all other medicines you are using to avoid adverse reactions. Common side effects of INVOKANA include urinary tract infections, increased urination, and yeast infections. Although rare, more serious side effects such as ketoacidosis, kidney problems, or a significant drop in blood pressure can occur. Due to the risk of dizziness or fainting, caution is advised when driving or operating heavy machinery until you know how INVOKANA affects you. Always prioritize safety and report any unusual symptoms to your healthcare provider immediately.